Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Steven, Sebastian; Oelze, Matthias; Hanf, Alina et al.

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats

REDOX BIOLOGY. Bd. 13. 2017 S. 370-385


Hanf, Alina; Steven, Sebastian; Oelze, Matthias et al.

The SGLT2 Inhibitor Empagliflozin Improves the Primary Diabetic Complications in ZDF Rats

FREE RADICAL BIOLOGY AND MEDICINE. Bd. 112. 2017 S. 112-113


Tome-Stangl, Lydia; Schaetzel, Cornelia; Tenzer, Stefan et al.

The soluble loop BC region guides, but not dictates, the assembly of the transmembrane cytochrome b(6)

PLOS ONE. Bd. 12. H. 12. 2017


Efferth, Thomas; Paul, Norbert W.

Threats to human health by great ocean garbage patches

The Lancet Planetary Health. Bd. 1. H. 8. 2017 S. e301–e303


Nussbaum, Kathrin; Burkhard, Sara H.; Ohs, Isabel et al.

Tissue microenvironment dictates the fate and tumorsuppressive function of type 3 ILCs

JOURNAL OF EXPERIMENTAL MEDICINE. Bd. 214. H. 8. 2017 S. 2331-2347


Lemmermann, Niels A. W.; Reddehase, Matthias J.

TLR3-independent activation of mast cells by cytomegalovirus contributes to control of pulmonary infection

CELLULAR & MOLECULAR IMMUNOLOGY. Bd. 14. H. 6. 2017 S. 479-481


Distler, Ute; Tenzer, Stefan

Tools for Pathogen Proteomics: Fishing with Biomimetic Nanosponges

ACS NANO. Bd. 11. H. 12. 2017 S. 11768-11772


Schermann, A. I.; Lorenz, B.; Tenzer, S. et al.

Towards vaccine development: from mice to humans-cross-reactivity of immunogenic antigens by human T cells identified in experimental leishmaniasis

EXPERIMENTAL DERMATOLOGY. Bd. 26. H. 3. 2017 S. E74-E74


Lopez, Pamela Aranda; Denny, Mark; Hartmann, Ann-Kathrin et al.

Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection

JOURNAL OF DERMATOLOGICAL SCIENCE. Bd. 87. H. 3. 2017 S. 252-259


Rafei-Shamsabadi, D.; Dorn, B.; van dePoel, S. et al.

Type 2 innate lymphoid cells act as regulators of type I driven TNCB contact hypersensitivity

EXPERIMENTAL DERMATOLOGY. Bd. 26. H. 3. 2017 S. E55-E55